— Know what they know.
Not Investment Advice
Also trades as: 0QZU.L (LSE) · $vol 1M · VX1.DE (XETRA) · $vol 0M

VRTX NASDAQ

Vertex Pharmaceuticals Incorporated
1W: -3.8% 1M: -0.9% 3M: -9.1% YTD: -4.1% 1Y: -3.0% 3Y: +25.6% 5Y: +99.7%
$434.52
+0.98 (+0.23%)
 
Weekly Expected Move ±3.1%
$410 $423 $437 $450 $463
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 50 · $110.3B mcap · 253M float · 0.505% daily turnover · Short 35% of daily vol

📊 Key Metrics

TTM
$12B
Revenue
+10.4% YoY
$4B
Net Income
+538.7% YoY
$4B
Free Cash Flow
+394.9% YoY
86.8%
Gross Margin
38.1%
Op. Margin
34.5%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE24.7%
ROA17.8%
ROIC25.2%

Valuation

P/E25.5
P/B5.7
EV/EBITDA21.5

Leverage

Debt/Equity0.21
Current Ratio2.90
Interest Cov.488.1x

Quality Scores

Piotroski F7/9
Altman Z11.35
Beneish M-2.21

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms